1[1]Matthaei S, Stumvoll M, Kellerer M, et al. Pathophysiology and Pharmacological treatment of insulin resistance. Endocrine Review 2000;21:585～618.
2[2]DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long - term complications in insulin - dependent diabetes mellitus. N Eng J Med 1993 ;329:977～ 986.
3[3]UKPDS Group. Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998;352:837～853.
4[4]Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non - insulin - dependent diabetes mellitus: a randomized prospective 6 - year study. Diabetes Res Clin Pract 1995 ;28:103～ 117.
5[5]Lindstrom T, Eriksson P, Olsson AG, et al. Longterm improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care 1994;17:719～722.
3[3]HarlandJO, Unwin N, Bhopal RS, et al. Low levels of cardiovascular risk factors and coronary heart disease in a UKChinese population[J] .Epidemiol Community Health, 1997,51:642
4[5]UK Prospective Diabetes Study Group. Tight blood pressurecontrol and risk of macrovascular and microvascular complications in type 2 diabetes[J ]. UKPDS 38.BM J, 1998, 17:703
5[8]Chan JCN, Cockram CS. Diabetes in the Chinese populationand its implications for health care[J] . Diabetes Care, 1997,20: 1785
6陈家伟.糖尿病与动脉粥样硬化[J].第三届分子糖尿病学研讨会论文编,2001,(17).
7余叶蓉.胰岛素抵抗与糖尿病大血管病变[J].第三届分子糖尿病学研讨会论文编,2001,:13.
8[23]UK prospective diabetes study(UKPDS) group. Intensivebloodglucose control with sulphonylureas or insulin comparedwith conventional treatment and risk of complications in patients with type 2diabetes (UKPDS 33) [J] .Lancet, 1998,352: 837
